Search research articles
Contact Us
Filters
Showing results (11-20 of 92) with videos related to
Page
of 10
Sort By:
Current Neurology and Neuroscience Reports
|
September 11, 2014
Gut microbiome and multiple sclerosis
Pavan Bhargava, Ellen M Mowry
Therapeutic Advances in Neurological Disorders
|
November 2, 2016
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis
Pavan Bhargava, Scott D Newsome
Comparative Medicine
|
April 16, 2013
Animal models of sleep disorders
Linda A Toth, Pavan Bhargava
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 23, 2020
Metabolomics in multiple sclerosis disease course and progression
Pavan Bhargava, Daniel C Anthony
CNS Drugs
|
January 23, 2023
The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
Dimitrios C Ladakis, Pavan Bhargava
Brain : a Journal of Neurology
|
October 18, 2013
The expanding spectrum of aetiologies causing retinal microcystic macular change
Pavan Bhargava, Peter A Calabresi
Pediatric Neurology
|
September 24, 2013
A pediatric case of painful legs and moving toes syndrome
Pavan Bhargava, Vijay Pandav, Shubhangi Peche
Mayo Clinic Proceedings
|
May 6, 2015
Familial transient global amnesia
Sudeepta Dandapat, Pavan Bhargava, Thomas A Ala
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 4, 2022
Response to-<i>Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases</i>
Pavan Bhargava, Norman Haughey, Peter A Calabresi
Journal of Neuroimmunology
|
February 12, 2015
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls
Pavan Bhargava, Anne Gocke, Peter A Calabresi
Page
of 10
Search research articles
Search
Showing results (11-20 of 92) with videos related to
Sort By:
Page
of 10
Current Neurology and Neuroscience Reports
|
September 11, 2014
Gut microbiome and multiple sclerosis
Pavan Bhargava, Ellen M Mowry
Therapeutic Advances in Neurological Disorders
|
November 2, 2016
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis
Pavan Bhargava, Scott D Newsome
Comparative Medicine
|
April 16, 2013
Animal models of sleep disorders
Linda A Toth, Pavan Bhargava
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 23, 2020
Metabolomics in multiple sclerosis disease course and progression
Pavan Bhargava, Daniel C Anthony
CNS Drugs
|
January 23, 2023
The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
Dimitrios C Ladakis, Pavan Bhargava
Brain : a Journal of Neurology
|
October 18, 2013
The expanding spectrum of aetiologies causing retinal microcystic macular change
Pavan Bhargava, Peter A Calabresi
Pediatric Neurology
|
September 24, 2013
A pediatric case of painful legs and moving toes syndrome
Pavan Bhargava, Vijay Pandav, Shubhangi Peche
Mayo Clinic Proceedings
|
May 6, 2015
Familial transient global amnesia
Sudeepta Dandapat, Pavan Bhargava, Thomas A Ala
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 4, 2022
Response to-<i>Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases</i>
Pavan Bhargava, Norman Haughey, Peter A Calabresi
Journal of Neuroimmunology
|
February 12, 2015
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls
Pavan Bhargava, Anne Gocke, Peter A Calabresi
Page
of 10